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AbsTrACT
background and purpose Triage tools to identify 
candidates for thrombectomy are of utmost importance 
in acute stroke. No prognostic tool has yet gained any 
widespread use. We compared the predictive value of 
various models based on National Institutes of Health 
Stroke Scale (NIHSS) subitems, ranging from simple to 
more complex models, for predicting large artery occlusion 
(LAO) in anterior circulation stroke.
Methods Patients registered in the SITS international 
Stroke Register with available NIHSS and radiological 
arterial occlusion data were analysed. We compared 2042 
patients harbouring an LAO with 2881 patients having 
no/distal occlusions. Using binary logistic regression, we 
developed models ranging from simple 1 NIHSS-subitem to 
full NIHSS-subitems models. Sensitivities and specificities 
of the models for predicting LAO were examined.
results The model with highest predictive value included 
all NIHSS subitems for predicting LAO (area under the 
curve (AUC) 0.77), yielding a sensitivity and specificity of 
69% and 76%, respectively. The second most predictive 
model (AUC 0.76) included 4-NIHSS-subitems (level of 
consciousness commands, gaze, facial and arm motor 
function) yielding a sensitivity and specificity of 67% 
and 75%, respectively. The simplest model included only 
deficits in arm motor-function (AUC 0.72) for predicting 
LAO, yielding a sensitivity and specificity of 67% and 72%, 
respectively.
Conclusions Although increasingly more complex models 
yield a higher discriminative performance for predicting 
LAO, differences between models are not large. Assessing 
grade of arm dysfunction along with an established 
stroke-diagnosis model may serve as a surrogate measure 
of arterial occlusion-status, thereby assisting in triage 
decisions.
InTroduCTIon
Stroke is one of the leading causes of death 
and disability worldwide, afflicting approxi-
mately 15 million people each year, of which 
10 million patients either die or suffer from 
permanent disability.1 For many years, intra-
venous thrombolysis with recombinant tissue 
plasminogen activator (r-tPA) alteplase was 
the only available pharmacological treat-
ment for acute ischaemic stroke, improving 
long-term functional outcome after stroke.2 
Recently, several randomised controlled trials 
have proven the benefit of endovascular 
thrombectomy using stent-retrievers in 
large artery occlusion (LAO) for anterior 
circulation stroke within 6 hours of symptom 
onset and in selected cases up to 24 hours after 
symptom onset.3–5 These results have revolu-
tionised the management of acute ischaemic 
stroke. However, the beneficial effects of 
endovascular thrombectomy have been 
shown to be time-dependent, decreasing with 
increased time from symptom onset to reper-
fusion.6 7 The need of prehospital tools rapidly 
identifying patients likely harbouring an LAO 
amenable to endovascular treatment have 
sparked the publication of several scales.8–15 
These scales aim at directing patients with a 
high probability of LAO to comprehensive 
stroke centres with endovascular capabili-
ties, potentially reducing the time to reper-
fusion.8–15 None of these scales have so far 
gained widespread use, and only one of the 
scales has been validated prospectively in a 
prehospital setting.13 All scales have incorpo-
rated all or subitems of the National Institutes 
of Health Stroke Scale (NIHSS), as stroke 
severity has been shown to be an important 
predictor of LAO.16–18 Using the full NIHSS 
in the prehospital setting is time-consuming, 
and the need for simple prediction rules is 
evident.
The aim of the current study is to compare 
the performance of various models for 
predicting LAO based on NIHSS subitems, 
ranging from simple to more complex models.
MeThods And MATerIAls
The study was based on patients registered 
in the Safe Implementation of Treatments in 
Stroke (SITS)-International Stroke Treatment 
Register (SITS-ISTR) between 1 December 
2012 and 23 October 2015. Only patients 
with available CT angiography/MR angi-
ography (CTA/MRA) and baseline NIHSS 
data treated with intravenous alteplase and/
or endovascular thrombectomy were consid-
ered. The time period was chosen based on 
the time of implementation in the database of 
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additional variables for registering detailed information 
on arterial occlusion site using baseline CTA/MRA. Data 
for the current study were contributed by hospitals which 
reported specified arterial occlusion sites in at least 20 
patients in whom any occlusion was reported as present. 
This selection of experienced centres was done in order 
to ensure a high quality registration of arterial occlusion 
data.
The SITS-ISTR is a multinational, prospective, observa-
tional monitoring register documenting data for centres 
using various treatments in acute ischaemic stroke. The 
aims of the register, collection of data and structure of 
the database have been described previously.19 Baseline 
and demographic characteristics, stroke severity per the 
NIHSS, arterial occlusion status assessed using CTA/
MRA, risk factors, time logistics, medication history, 
imaging data and 3-month outcome data were registered.
ethical approval and data monitoring
Ethical approval or patient consent for participation in 
SITS-ISTR was obtained in countries that required this; 
other countries approved the register for conduct as an 
anonymised audit. The SITS-MOST II study was approved 
by the Stockholm Regional Ethics Committee. The SITS 
International Coordination Office performed regular 
online monitoring of the SITS-ISTR data online and 
checked individual patient data on a regular basis to iden-
tify errors or inconsistencies.
outcome measurements
Arterial occlusion was defined as a complete occlusion or 
less than 50% filling of the affected vascular territory on 
CTA/MRA. LAO was defined as occlusion of any segment 
of the internal carotid artery, carotid terminus, M1 branch 
of the middle cerebral artery or basilar artery. In cases 
where more than one arterial segment was reported as 
being occluded, the most proximal vessel was registered 
for the analysis. The control population was defined as 
patients without visible occlusions or with more distal 
occlusions (M2, M3, distal to M3; A1, A2, distal to A2, P1, 
P2 and P3).
All assessments of imaging studies were done according 
to clinical routine at centres participating in the SITS-
ISTR, and no central assessment of imaging data was 
routinely performed.
statistical analysis
For baseline and clinical data, univariate analysis was 
performed comparing patients with and without LAO. 
Proportions were calculated for categorical variables, 
dividing the number of events with the total number 
excluding missing/unknown cases. For continuous vari-
ables, medians were calculated. Statistically significant 
differences between proportions were assessed using the 
χ² method, and the Mann–Whitney U-test was used for 
medians.
The most highly predictive models, exploratively identi-
fied using highest area under the curve (AUC) by receiver 
operating characteristic (ROC) analysis and varying from 
single-variable models to more complex models, were 
developed using binary logistic regression analysis.
We assessed for differences between the models using 
both comparisons of the area under the ROC curves 
(likelihood ratio tests and Wald tests) as well as IDI (Inte-
grated discrimination improvement) and NRI (net reclas-
sification improvement) statistics to judge the value of 
added items. Sensitivities and specificities for predicting 
LAO were determined at three distinct cut-offs (defini-
tion see below). The various models were solely based on 
NIHSS subitems registered in a continuous fashion sepa-
rating different degrees of dysfunction.
Using binary logistic regression, we derived the most 
predictive models for predicting LAO based on subitems 
of the NIHSS. We investigated 1-item, 2-items, 3-items, 
4-items models as well as a model including all NIHSS 
subitems. For each model, whether a 1-item, 2-items, 
3-items, 4-items or full NIHSS subitem model, we inves-
tigated which combination of items yielded the highest 
AUC and subsequently chose these models for further 
comparison. Within each type of model (1-item, 2-items, 
3-items or 4-items model), the AUCs of the different 
subitem combinations were compared using likelihood 
ratio tests. In this way, we finally chose one specific 
item-combination for each 1-item, 2-items, 3-items and 
4-items model based on maximising the AUC for LAO 
prediction. For each model, we assessed the sensitivity 
and specificity for LAO at three different cut points: at 
an optimal cut-point maximising the Youden index, at a 
cut-point maximising the specificity (as close to 80% as 
possible) and at a cut-point maximising the sensitivity 
(as close to 80% as possible). In addition to investigating 
the above-mentioned models, we decided to specifically 
include a hemiparesis model including the arm and leg 
NIHSS-subitems (NIHSS item 5 and NIHSS item 6) as 
well as a model solely based on the total NIHSS score, 
in contrast to the full-items model which included each 
NIHSS subitems as a separate predictor. In order to 
better appreciate the performance of our models, we 
also performed a comparison with selected pre-existing 
LAO prediction instruments (PASS, RACE, G-FAST and 
CPSSS). These scales were computed on our study-base 
in accordance with the descriptions in the respective orig-
inal articles.10 12 13 20
resulTs
Between 1 December 2012 and 23 October 2015, 5112 
patients with available CTA/MRA data from large-volume 
centres were registered in the database. Baseline NIHSS 
(and complete NIHSS subitem data) was available in 96% 
of the study group (4923/5112). Of these, 2042 patients 
(41%) had a LAO, while 2881 patients (59%) had either 
no occlusion or more distal occlusions. Table 1 summa-
rises the baseline characteristics, comparing patients with 
LAO with patients  without LAO, with complete NIHSS 
baseline data.
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Table 1 Baseline clinical characteristics of patients with and without LAO
Baseline parameter
LAO (n=2042) Non-LAO (n=2881)
P valuesNo/Total
Median or 
proportion (%) No./Total
Median or 
proportion (%)
Age 2035 72 2881 71 0.189
Gender, female 965/2042 47.3% 1261/2881 43.8% 0.015
NIHSS at baseline 2042 16 2881 8 <0.01
Weight, kg 2042 75 2881 78 <0.01
Glucose, mmol/L 1892 6.7 2800 6.6 0.824
Total cholesterol 1259 4.6 2119 4.7 0.165
Systolic BP 1963 150 2848 156 <0.01
Diastolic BP 1963 80 2848 84 <0.01
Prestroke mRS score>2 81/1978 4.1% 135/2800 4.8% 0.234
Hypertension 1345/2033 66.2% 1958/2876 68.1% 0.157
Diabetes 383/2033 18.8% 648/2876 22.5% <0.01
Hyperlipidaemia 635/2008 31.6% 912/2857 31.9% 0.826
Current smoker 319/1948 16.4% 458/2789 16.4% 0.967
Previous stroke 204/2032 10.0% 396/2870 13.8% <0.01
Previous TIA 106/2032 5.2% 177/2870 6.2% 0.160
Atrial fibrillation 495/2026 24.4% 486/2867 17.0% <0.01
Heart failure 176/2021 8.7% 201/2864 7.0% 0.029
Aspirin 566/2026 27.9% 931/2868 32.5% <0.01
Oral anticoagulants 158/2031 7.8% 105/2871 3.7% <0.01
Clopidogrel 119/2029 5.9% 165/2870 5.7% 0.864
Oral antidiabetics 218/1999 10.9% 404/2852 14.2% <0.01
Statins 551/2026 27.2% 803/2871 28.0% 0.551
LAO, any internal carotid artery occlusion and/or M1 occlusion and/or basilar occlusion; non-LAO, M2 M3, ACA, PCA or none.
BP, blood pressure; LAO, large artery occlusion; mRS, modified Rankin Score; NIHSS, National Institutes of Health Stroke Scale. 
Patients with and without LAO differed somewhat 
regarding several baseline variables, however not to any 
larger extent although being statistically significant, see 
table 1. The most notable difference between patients 
with and without LAO was in the total baseline NIHSS 
score at 16 vs 8, respectively, as well as higher systolic 
blood pressure in patients without LAO and higher prev-
alence of atrial fibrillation in patients with LAO.
Models for predicting lAo
The most predictive models with increasing number of 
included subitems are given below. The sensitivity and 
specificity of the models at the optimum Youden cut-off, 
at the maximum specificity cut-off and at the maximum 
sensitivity cut-off are given in table 2. Figure 1 depicts 
the AUC for LAO comparing the most predictive 1-item, 
4-items and full-items models. The AUCs for the models 
given below were all statistically significantly different 
from each other at the 5% level (assessed using likeli-
hood ratio tests and Wald tests). An online supplemen-
tary table e-1, displays the proportion of patients being 
detected using the various models and cut-offs as well as 
positive and negative predictive values (PPVs and NPVs). 
Online supplementary table e-2 displays the IDI and NRI 
statistics, assessing the additional value of adding extra 
subitems to increasingly complex models.
1-item model
The 1-item model associated with the highest AUC (0.72) 
including only NIHSS subitem 5, arm motor function. 
The optimum Youden cut-off (NIHSS item 5≥3) resulted 
in a sensitivity and specificity of 67% and 72%, respec-
tively. At the high-specificity cut-off (NIHSS item 5=4) a 
sensitivity and specificity of 53% and 81%, respectively, 
was seen. The high sensitivity cut-off (NIHSS item 5≥2) 
resulted in a sensitivity and specificity of 77% and 57%, 
respectively.
A 1-item model including only NIHSS subitem 6, leg 
motor function, yielded an AUC of 0.71.
2-items model
The 2-items model associated with the highest AUC 
(0.75) included NIHSS subitems 5 and 2, arm motor func-
tion and gaze, respectively. The optimum Youden cut-off 
resulted in a sensitivity and specificity of 68% and 73%, 
respectively, at the high-specificity cut-off a sensitivity and 
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Table 2 Sensitivity and specificity for predicting LAO for various models at optimum cut-off, high specificity cut-off and high 
sensitivity cut-off
Model AUC P values
Optimum Youden cut-off High specificity cut-off High sensitivity cut-off
Sens Spec Sens Spec Sens Spec
NIH item 5 0.72 – 67
(NIHSS 5≥3)
72
(NIHSS 5≥3)
53
(NIHSS 5=4)
81
(NIHSS 5=4)
77
(NIHSS 5≥2)
57
(NIHSS 5≥2)
NIHSS item 
5+NIHSS item 2
0.75 <0.05 68 73 64 76 82 53
NIHSS item 
5+NIHSS item 
2+NIHSS item 4
0.76 <0.05 70 72 61 80 80 59
NIHSS item 
5+NIHSS item 2+
NIHSS item 
4+NIHSS item 1C
0.76 <0.05 67 75 61 80 79 59
Full-item NIHSS 0.78 <0.05 69 76 62 80 81 59
Total NIHSS score 0.76 <0.05 69 73 60 80 80 57
NIHSS item 
5+NIHSS item 6
0.73 <0.05 65 74 53 82 79 52
The p values for the AUCs describe likelihood ratios tests comparing each model with the simple arm paresis model (NIH item 5). For the 
1-item model including subitem 5, arm function, we have in italics given the respective subitem cut-off for the three sensitivity/specificity 
scenarios. NIHSS item 2=gaze; NIHSS item 1C=level of consciousness commands; NIHSS item 4=facial motor function; NIHSS item 
5=arm motor function; NIHSS item 6=leg motor function.
AUC, area under the curve; LAO, large artery occlusion; NIHSS, National Institutes of Health Stroke Scale. 
Figure 1 AUC for predicting LAO, comparing the most 
predictive NIHSS 1-item, 4-items and full-items models. 
The 1-item model included NIHSS subitem 5 (arm function), 
the 4-items model included subitems 1C, 2, 4 and 5 
(level of consciousness commands, gaze, facial and arm 
motor function. The full-items model included all NIHSS 
subitems. AUC, area under the curve; LAO, large artery 
occlusion; NIHSS, National Institutes of Health Stroke Scale. 
specificity of 64% and 76% was seen, and the high sensi-
tivity cut-off resulted in a sensitivity and specificity of 82% 
and 53%, respectively.
3-items model
The 3-items model associated with the highest AUC 
(0.755) included NIHSS subitems 5, 2 and 4, arm motor 
function, gaze and facial motor function, respectively. At 
the optimum Youden cut-off a sensitivity and specificity 
of 70% and 72% was seen, the high-specificity cut-off 
resulted in a sensitivity and specificity of 61% and 80%, 
and at the high sensitivity cut-off a sensitivity and speci-
ficity of 80% and 59% was seen.
4-items model
The 4-items model associated with the highest AUC 
(0.76) included NIHSS subitems 5, 2, 4 and 1C, arm 
motor function, gaze, facial motor function and level 
of consciousness commands, respectively. The optimum 
Youden cut-off resulted in a sensitivity and specificity of 
67% and 75%, respectively, at the high-specificity cut-off 
a sensitivity and specificity of 61% and 80% was seen, and 
the high sensitivity cut-off resulted in a sensitivity and 
specificity of 79% and 59%.
Full-items model
The full-items model resulted in an AUC of 0.78. The 
optimum Youden cut-off yielded a sensitivity and speci-
ficity of 69% and 76%, at the high-specificity cut-off a 
sensitivity and specificity of 62% and 80% was seen, and 
the high sensitivity cut-off resulted in a sensitivity and 
specificity of 81% and 59%.
hemiparesis model
The hemiparesis model, including arm and leg function 
(NIHSS subitems 5 and 6), was associated with a AUC 
of 0.73. At the optimum Youden cut-off a sensitivity and 
specificity of 65% and 74% was seen, the high-specificity 
cut-off resulted in a sensitivity and specificity of 53% and 
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82%, and at the high sensitivity cut-off a sensitivity and 
specificity of 79% and 52% was seen.
Total nIhss score model
The model including the total NIHSS score as a predictive 
model was associated with a AUC of 0.76. The optimum 
Youden cut-off (NIHSS ≥13) score resulted in a sensi-
tivity and specificity of 69% and 73%, at the high-speci-
ficity cut-off (NIHSS ≥14) a sensitivity and specificity of 
60% and 80% was seen, and the high sensitivity cut-off 
(NIHSS ≥9) yielded a sensitivity and specificity of 80% 
and 57%.
sensitivity analysis including M2/A1
When including M2, A1 and P1 occlusions in the defi-
nition of LAO, AUC of the 1-item model including arm 
paresis was 0.71, the AUC of the 4-items model including 
NIHSS subitems 5, 2, 4 and 1C was 0.76 and the AUC of 
the full-items NIHSS 0.77.
sensitivity analysis excluding basilar artery occlusions
When excluding basilar artery occlusions from the defi-
nition of LAO, AUC of the 1-item model including arm 
paresis was 0.72, the AUC of the 4-items model including 
NIHSS subitems 5, 2, 4 and 1C was 0.76 and the AUC of 
the full-items NIHSS 0.77.
Pre-existing lAo models
The results of the comparison of the arm paresis model 
with the four selected pre-existing LAO prediction scales 
can be seen in online supplementary table e-3.
dIsCussIon
In the era of endovascular thrombectomy in acute 
ischaemic stroke, reducing time to reperfusion in patients 
harbouring LAO is of the utmost importance.7 Although 
baseline stroke severity measured by the NIHSS score 
predicts the presence of arterial occlusions,8 16–18 21 22 the 
full NIHSS is time-consuming and probably too compli-
cated in the prehospital setting. Several attempts at devel-
oping simplified scores for use in the prehospital setting 
have been done; however, none of these has to our knowl-
edge gained any widespread use.8–10 12–15
In this study, we show that although increasing numbers 
of included NIHSS subitems in LAO prediction models 
leads to better prediction, the differences do not seem 
to be clinically relevant. A simple predictive model only 
including the arm motor function item of the NIHSS 
shows both sensitivities, specificities, PPVs and NPVs 
(67%, 72%, 63% and 75%, respectively) quite close to 
the values for a model including the full range of NIHSS 
subitems (69%, 76%, 67% and 77%, respectively). To our 
knowledge, no study has investigated such a simple model 
previously.
Different settings and situations may need different 
trade-offs between sensitivity and specificity. In a recent 
article from the SITS collaborators, two different clinical 
scenarios were described.23 In the first scenario, a patient 
assessed by paramedics at an early time-point or with a 
short transfer-time to a comprehensive stroke centre 
with endovascular capabilities was considered. In such a 
patient, a predictive model with a high sensitivity would be 
desirable. Using an unadjusted cut-off NIH item 5 (arm 
function)≥2 gave a sensitivity, specificity, PPV and NPV of 
77%, 57%, 57% and 78%, quite similar to the adjusted 
full-items NIH model, which gave a sensitivity, specificity, 
PPV and NPV of 81%, 59%, 58% and 81%, respectively. 
This corresponds to the high-sensitivity cut-off of the total 
NIHSS score ≥9. In the second scenario, a patient eval-
uated by paramedics close to the end of the IVT time-
window or with a long transfer-time to a comprehensive 
stroke centre was considered. A high specificity for LAO 
would be desirable in this situation, in order to reduce 
the number of futile transfers. Using a cut-off NIH item 
5 (arm function)=4 gave a specificity, sensitivity, PPV and 
NPV of 81%, 53%, 66% and 71%, not very far from the 
adjusted full-items NIH model which gave a specificity, 
sensitivity, PPV and NPV of 80%, 62%, 69% and 75%. 
This corresponds to the high-specificity cut-off of the total 
NIHSS score ≥14.
In summary, although the more complex models 
perform statistically significantly better than our simple 
arm dysfunction model (see table 2 and online supple-
mentary table e-2), differences are not large and the 
simple model performs reasonably well in both clinical 
scenarios. We performed a comparison of the simple 
arm paresis model with four pre-existing LAO prediction 
instruments (CPSSS, PASS, G-FAST and RACE scores), 
see online supplementary table e-3. The AUCs of three 
of the pre-existing models differed significantly from 
the arm-paresis model, CPSSS and RACE performing 
better and PASS worse. G-FAST did not differ signifi-
cantly. However, the AUCs of all five models were similar, 
suggesting a similar predictive performance.
Prediction of LAO without vessel imaging will always 
lead to either missing patients harbouring a treatable 
arterial occlusion or unnecessary transfer of patients 
without treatable occlusions to comprehensive stroke 
centres. However, simple prediction rules may improve 
patient selection and potentially lead to improved 
onset-to-reperfusion times. Using the high-specificity 
cut-off (NIH item 5=4) as a triage tool to endovascular 
centres would identify 33% of our study population as 
possible LAO candidates (see online supplementary 
table e-1), the PPV amounting to 66%, ie, nearly 7/10 
successful transfers. Using the high-sensitivity cut-off 
(NIH item 5≥2) as a triage tool would identify roughly 
60% of our study population (see online supplementary 
table e-1), the PPV amounting to 57%, ie, nearly 6/10 
successful transfers (see online supplementary table e-1). 
The choice of cut-off depends on the clinical situation 
and local circumstances as outlined above. We suggest 
that a thorough screening for severity of arm motor func-
tion can be used as an LAO screening step after confirma-
tion of likely stroke diagnosis has been performed using 
a good stroke recognition score at the primary screening 
 o
n
 24 July 2019 by guest. Protected by copyright.
http://svn.bmj.com/
Stroke Vasc Neurol: first published as 10.1136/svn-2018-000165 on 3 Septem
ber 2018. Downloaded from
 
220Cooray C, et al. Stroke and Vascular Neurology 2018;3:e000165. doi:10.1136/svn-2018-000165
Open access 
step like the FAST score.24 Previous studies have shown 
an excellent inter-rater reliability of the motor subitems 
of the NIHSS score as well as the possibility of its use by 
non-physicians undergoing a brief training period.25 26 
We therefore believe that our simple arm paresis model 
would suit the prehospital setting.
This study bears with it certain limitations inherent 
to the observational design. Our definition of LAO did 
not include M2 occlusions which may be amenable to 
treatment; however, a sensitivity analysis including M2 
occlusions in the LAO definition showed very similar 
results to those presented in the main results. In addi-
tion, a subanalysis excluding basilar occlusions from the 
definition of LAO also presented very similar results. 
Although we extend our results to a prehospital setting, 
assessments of the NIHSS registered in the database 
were performed in a hospital-setting. Also, our study 
is based on patients treated with intravenous-tPA and/
or endovascular thrombectomy and may not be valid 
for unselected patients with a prehospital suspicion of 
stroke. However, previous studies on unselected isch-
aemic stroke cohorts have shown LAO proportions 
similar to our cohort.27 Our selection of patients with 
documented ischaemic stroke is a potential source of 
bias, as both haemorrhagic stroke and stroke mimics will 
be a part of the assessed population in the prehospital 
phase. Despite these limitations, we believe that our 
findings are of interest.
ConClusIon
Although increasingly more complex clinical models yield 
a higher discriminative performance for predicting LAO, 
the difference compared with extremely simple models is 
not very large. Balancing predictive performance against 
ease of use and practicality, simply assessing the grade of 
arm dysfunction may serve as a surrogate measure of LAO 
status, and in conjunction with a validated stroke recogni-
tion instrument, may assist in decision making in guiding 
high-risk patients to comprehensive stroke centres with 
endovascular treatment capabilities. These findings need 
to be confirmed in a future prospective study on prehos-
pital triage.
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